Vycor Medical (VYCO) Notes Payables (2010 - 2026)

Vycor Medical (VYCO) reported Notes Payables of $312920.0 for Q1 2026, up 1.65% year-over-year from $307832.0 in Q1 2025, and down 4.3% quarter-over-quarter from $326978.0 in Q4 2025.

Vycor Medical (VYCO) Notes Payables (2010 - 2026) Analysis & Trends

Vycor Medical (VYCO) has 17 years of Notes Payables data on file, last reported at $312920.0 in Q1 2026.

  • Notes Payables for Q1 2026 came in at $312920.0, up 1.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $312920.0 (up 1.65% YoY), and the FY2025 annual result was $326978.0, up 0.86% from the prior year.
  • Notes Payables slipped to $312920.0 in Q1 2026 per VYCO's latest filing, from $326978.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $340939.0 in Q3 2025 and troughed at $302121.0 in Q2 2022.
  • A 5-year average of $319125.0 and a median of $313140.0 in 2024 frame the typical range for Notes Payables.
  • On a YoY basis, Notes Payables climbed as much as 5.25% in 2022 and fell as far as 27.58% in 2022.
  • A 5-year view of Notes Payables shows it stood at $324711.0 in 2022, then rose by 1.1% to $328267.0 in 2023, then dropped by 1.24% to $324185.0 in 2024, then rose by 0.86% to $326978.0 in 2025, then declined by 4.3% to $312920.0 in 2026.
  • Business Quant data shows VYCO's Notes Payables at $312920.0 in Q1 2026, $326978.0 in Q4 2025, and $340939.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Vycor Medical - - 375,153.00

Historic Data

Download Data
DateValue
Mar 31, 2026 312,920.00
Dec 31, 2025 326,978.00
Sep 30, 2025 340,939.00
Jun 30, 2025 303,074.00
Mar 31, 2025 307,832.00
Dec 31, 2024 324,185.00
Sep 30, 2024 337,179.00
Jun 30, 2024 303,409.00
Mar 31, 2024 313,140.00
Dec 31, 2023 328,267.00
Sep 30, 2023 338,786.00
Jun 30, 2023 303,410.00
Mar 31, 2023 311,396.00
Dec 31, 2022 324,711.00
Sep 30, 2022 337,721.00
Jun 30, 2022 302,121.00
Mar 31, 2022 309,057.00
Dec 31, 2021 319,329.00
Sep 30, 2021 320,873.00
Jun 30, 2021 417,200.00